Livelsberger Financial Advisory Anixa Biosciences Inc Transaction History
Livelsberger Financial Advisory
- $4.77 Billion
- Q3 2024
A detailed history of Livelsberger Financial Advisory transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Livelsberger Financial Advisory holds 1,634 shares of ANIX stock, worth $4,395. This represents 0.11% of its overall portfolio holdings.
Number of Shares
1,634Holding current value
$4,395% of portfolio
0.11%Shares
2 transactions
Others Institutions Holding ANIX
# of Institutions
60Shares Held
5.56MCall Options Held
21KPut Options Held
6.7K-
Vanguard Group Inc Valley Forge, PA1.39MShares$3.75 Million0.0% of portfolio
-
D.A. Davidson & Co.671KShares$1.81 Million0.02% of portfolio
-
Laird Norton Trust Company, LLC621KShares$1.67 Million0.26% of portfolio
-
Ubs Group Ag529KShares$1.42 Million0.0% of portfolio
-
Mission Wealth Management, LP510KShares$1.37 Million0.04% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $82.5M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...